DMAC vs TRV · $157.4M cap vs P/E 14, rev $48.83B
DiaMedica Therapeutics Inc (DMAC) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
DMAC does not have a complete income-statement cache yet.
Latest reported TRV revenue for 2025-12-31 was $48.83B. Net income was $6.29B. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
DMAC currently screens at market cap $157.4M. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the DMAC and TRV stock pages for the full models.
Not investment advice.